127 related articles for article (PubMed ID: 3569423)
1. Development of tolerance and supersensitivity to phencyclidine in rats after repeated administration of phencyclidine.
Nabeshima T; Fukaya H; Yamaguchi K; Ishikawa K; Furukawa H; Kameyama T
Eur J Pharmacol; 1987 Mar; 135(1):23-33. PubMed ID: 3569423
[TBL] [Abstract][Full Text] [Related]
2. Role of dopaminergic and serotonergic neuronal systems in the prefrontal cortex of rats in phencyclidine-induced behaviors.
Yamaguchi K; Nabeshima T; Kameyama T
J Pharmacobiodyn; 1986 Dec; 9(12):987-96. PubMed ID: 3572718
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of phencyclidine-induced dopamine-dependent behaviors in rats after pretreatments with serotonin-depletors.
Yamaguchi K; Nabeshima T; Kameyama T
J Pharmacobiodyn; 1986 May; 9(5):479-89. PubMed ID: 2945001
[TBL] [Abstract][Full Text] [Related]
4. Serotonergic involvement in phencyclidine-induced behaviors.
Nabeshima T; Yamaguchi K; Hiramatsu M; Amano M; Furukawa H; Kameyama T
Pharmacol Biochem Behav; 1984 Sep; 21(3):401-8. PubMed ID: 6208563
[TBL] [Abstract][Full Text] [Related]
5. Risperidone prevents the development of supersensitivity, but not tolerance, to phencyclidine in rats treated with subacute phencyclidine.
Kitaichi K; Yamada K; Yoneda Y; Ogita K; Hasegawa T; Furukawa H; Nabeshima T
Life Sci; 1995; 56(7):531-43. PubMed ID: 7532775
[TBL] [Abstract][Full Text] [Related]
6. Phencyclidine-induced head-twitch response in rats treated chronically with methysergide.
Nabeshima T; Ishikawa K; Yamaguchi K; Furukawa H; Kameyama T
Eur J Pharmacol; 1987 Jan; 133(3):319-28. PubMed ID: 3556394
[TBL] [Abstract][Full Text] [Related]
7. Potentiation in phencyclidine-induced serotonin-mediated behaviors after intracerebroventricular administration of 5,7-dihydroxytryptamine in rats.
Nabeshima T; Yamaguchi K; Ishikawa K; Furukawa H; Kameyama T
J Pharmacol Exp Ther; 1987 Dec; 243(3):1139-46. PubMed ID: 2826756
[TBL] [Abstract][Full Text] [Related]
8. Role of dopaminergic and GABAergic mechanisms in discrete brain areas in phencyclidine-induced locomotor stimulation and turning behavior.
Yamaguchi K; Nabeshima T; Kameyama T
J Pharmacobiodyn; 1986 Dec; 9(12):975-86. PubMed ID: 3033192
[TBL] [Abstract][Full Text] [Related]
9. Phencyclidine-induced dopamine-dependent behaviors in chronic haloperidol-treated rats.
Yamaguchi K; Nabeshima T; Amano M; Yoshida S; Furukawa H; Kameyama T
Pharmacol Biochem Behav; 1985 Nov; 23(5):803-9. PubMed ID: 4080767
[TBL] [Abstract][Full Text] [Related]
10. Effect of lesions in the striatum, nucleus accumbens and medial raphe on phencyclidine-induced stereotyped behaviors and hyperactivity in rats.
Nabeshima T; Yamada K; Yamaguchi K; Hiramatsu M; Furukawa H; Kameyama T
Eur J Pharmacol; 1983 Aug; 91(4):455-62. PubMed ID: 6684578
[TBL] [Abstract][Full Text] [Related]
11. Behavioral effects of chronic phencyclidine administration in rats.
Sturgeon RD; Fessler RG; London SF; Meltzer HY
Psychopharmacology (Berl); 1982; 76(1):52-6. PubMed ID: 6805009
[TBL] [Abstract][Full Text] [Related]
12. Phencyclidine-induced stereotyped behaviors in rats following specific neurotoxin lesions of the striatum.
Nabeshima T; Yamaguchi K; Yamada K; Hiramatsu M; Furukawa H; Kameyama T
Eur J Pharmacol; 1983 Sep; 93(3-4):229-34. PubMed ID: 6416871
[TBL] [Abstract][Full Text] [Related]
13. Different effects of ethylketocyclazocine on phencyclidine- and N-allylnormetazocine-induced stereotyped behaviors in rats.
Hiramatsu M; Nabeshima T; Furukawa H; Kameyama T
Pharmacol Biochem Behav; 1987 Dec; 28(4):489-94. PubMed ID: 2893389
[TBL] [Abstract][Full Text] [Related]
14. Phencyclidine-induced stereotyped behaviors after injection of morphine and N-allylnormetazocine (SKF 10,047) in rats.
Nabeshima T; Hiramatsu M; Kameyama T
Pharmacol Biochem Behav; 1986 Jun; 24(6):1629-34. PubMed ID: 3016758
[TBL] [Abstract][Full Text] [Related]
15. Phencyclidine-induced head-weaving observed in mice after ritanserin treatment.
Nabeshima T; Ishikawa K; Yamaguchi K; Furukawa H; Kameyama T
Eur J Pharmacol; 1987 Jul; 139(2):171-8. PubMed ID: 2888667
[TBL] [Abstract][Full Text] [Related]
16. Phencyclidine-induced head-twitch responses as 5-HT2 receptor-mediated behavior in rats.
Nabeshima T; Ishikawa K; Yamaguchi K; Furukawa H; Kameyama T
Neurosci Lett; 1987 May; 76(3):335-8. PubMed ID: 3108730
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of phencyclidine-induced stereotyped behaviors in rats by thiorphan and bestatin.
Hiramatsu M; Nabeshima T; Fukaya H; Furukawa H; Kameyama T
Eur J Pharmacol; 1986 Jan; 120(1):69-74. PubMed ID: 3456306
[TBL] [Abstract][Full Text] [Related]
18. Phencyclidine-induced stereotyped behaviors after injection of ethylketocyclazocine, Mr 2266 and naltrexone in rats.
Nabeshima T; Hiramatsu M; Kameyama T
Brain Res; 1986 Jul; 378(2):234-9. PubMed ID: 3015356
[TBL] [Abstract][Full Text] [Related]
19. Effects of repeated phencyclidine treatment on serotonin transporter in rat brain.
Hori T; Abe S; Baba A; Suzuki T; Shiraishi H
Neurosci Lett; 2000 Feb; 280(1):53-6. PubMed ID: 10696810
[TBL] [Abstract][Full Text] [Related]
20. Role of nitric oxide in the development of tolerance and sensitization to behavioural effects of phencyclidine in mice.
Noda Y; Yamada K; Komori Y; Sugihara H; Furukawa H; Nabeshima T
Br J Pharmacol; 1996 Apr; 117(7):1579-85. PubMed ID: 8730757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
